Dr. Jean Y Blay, Prof, MD
Claim this profileStudies Plica Syndrome
Studies Pigmented Villonodular Synovitis
1 reported clinical trial
1 drug studied
More about Jean Y Blay, Prof, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jean Y Blay, Prof, MD has experience with
- Emactuzumab
Breakdown of trials Jean Y Blay, Prof, MD has run
Plica Syndrome
Pigmented Villonodular Synovitis
Testicular Germ Cell Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jean Y Blay, Prof, MD specialize in?
Jean Y Blay, Prof, MD focuses on Plica Syndrome and Pigmented Villonodular Synovitis. In particular, much of their work with Plica Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Jean Y Blay, Prof, MD currently recruiting for clinical trials?
No, Jean Y Blay, Prof, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jean Y Blay, Prof, MD has studied deeply?
Yes, Jean Y Blay, Prof, MD has studied treatments such as Emactuzumab.
What is the best way to schedule an appointment with Jean Y Blay, Prof, MD?
Apply for one of the trials that Jean Y Blay, Prof, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.